Details for New Drug Application (NDA): 005856
✉ Email this page to a colleague
NDA 005856 describes TRIDIONE, which is a drug marketed by Abbvie and is included in one NDA. Additional details are available on the TRIDIONE profile page.
The generic ingredient in TRIDIONE is trimethadione. Additional details are available on the trimethadione profile page.
The generic ingredient in TRIDIONE is trimethadione. Additional details are available on the trimethadione profile page.
Summary for 005856
| Tradename: | TRIDIONE |
| Applicant: | Abbvie |
| Ingredient: | trimethadione |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 005856
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL | Strength | 200MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 005
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 300MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 009
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 150MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
